Browse All Conditions

Explore 28,708 medical conditions with active and completed U.S. clinical trial data drawn from ClinicalTrials.gov. According to ClinicalTrials.gov, the NIH registry maintained by the National Library of Medicine contains more than 500,000 studies in more than 220 countries. The 2007 FDAAA requires registration for most FDA-regulated studies. See our methodology for refresh cadence.

PlainTrial's condition directory indexes every disease, disorder, syndrome, and medical condition with at least one clinical study registered on ClinicalTrials.gov. Each entry links to a per-condition profile page showing recruiting trials, completed studies, phase distribution, sponsor mix, and geographic coverage. We use the MeSH-aligned condition names submitted by trial sponsors to the National Library of Medicine, so a condition you find here is the same condition a clinician would search on PubMed or a researcher would tag in a grant application.

Use the alphabetical index to browse the full list, or sort by trial volume to find conditions with the deepest active research pipelines. Conditions with a "Recruiting" count in the third column have at least one trial currently enrolling participants - click through to see locations and eligibility. Conditions with high trial counts but zero recruiting slots usually reflect a maturing pipeline (Phase 3 studies are enrollment-closed) or a condition where standard-of-care has shifted research focus to combination therapies and post-approval surveillance.

The directory is comprehensive but not equally deep across conditions. Rare diseases may show fewer than a handful of trials because patient populations are limited - this is a feature of clinical research, not an indexing gap on our end. Common conditions (cancer subtypes, diabetes, hypertension, depression) show dozens to hundreds of studies because they attract the broadest sponsor investment. Every number on this page comes directly from ClinicalTrials.gov; we do not manually edit counts, and we update from the NLM bulk-export on a regular cadence so what you see reflects the most recent registry state we have ingested.

Breast Cancer1,251Healthy1,096Obesity1,057Prostate Cancer749Depression687Cancer621HIV Infections615Hypertension472Stroke456Non-Small Cell Lung Cancer455
A2,809B1,091C2,928D1,168E986F825G765H1,701I1,106J82K187L1,231M2,114N1,012O820P2,801Q24R1,691S3,009T967U528V509W238X47Y19Z17
Treemap Treemap of 10 categories, sized proportional to value. Breast Cancer 1,251 Healthy 1,096 Obesity 1,057 Prostate Cancer 749 Depression 687 Cancer 621 HIV Infections 615 Hypertension 472 Stroke 456 Non-Small Cell Lu… 455

† Condition counts include only the 60,823 of 175,638 indexed trials (35%) that have a condition list: 92% of recruiting and active trials but 24% of completed ones, so completed and closed studies are under-counted. How the counts are built

Condition Trials†
Advanced Solid Malignant Tumor 1
Advanced Solid Neoplasms 1
Advanced Solid Tumor 190
Advanced Solid Tumor and Lymphoma Malignancies 1
Advanced Solid Tumor Cancer 2
Advanced Solid Tumor Historically Known for High EphA2 Expression 1
Advanced Solid Tumor, Adult 1
Advanced Solid Tumors 145
Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab 1
Advanced Solid Tumors Cancer 10
Advanced Solid Tumors or Hematologic Malignancies 1
Advanced Solid Tumors That Are MTAP Deficient 1
Advanced Solid Tumors Which Are cMET-dependent 1
Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 1
Advanced Solid Tumors With and Without Brain Metastases 1
Advanced Solid Tumors With FGFR1 Amplication 1
Advanced Solid Tumors With FGFR2 Amplication 1
Advanced Solid Tumors With FGFR3 Mutation 1
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast 1
Advanced Solid Tumors With KRAS G12C Mutations 1
Advanced Solid Tumors With MAPK Pathway Mutations 1
Advanced Solid Tumours 4
Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor 1
Advanced Squamous Non Small Cell Lung Cancer 1
Advanced Squamous Non-Small Cell Lung Carcinoma 1
Advanced Squamous Tumors 1
Advanced Stage Parkinson's Disease 1
Advanced Synovial Sarcoma 1
Advanced Systemic Mastocytosis 1
Advanced Systemic Mastocytosis (AdvSM) 1
Advanced Thyroid Gland Medullary Carcinoma 1
Advanced Triple-Negative Breast Carcinoma 2
Advanced Tumors 2
Advanced Unresectable Gastric Adenocarcinoma 1
Advanced Unresectable Hepatocellular Carcinoma 1
Advanced Unresectable Melanoma 1
Advanced Unresectable Solid Tumor 1
Advanced Upper Gastrointestinal Tract Adenocarcinoma 1
Advanced Ureter Urothelial Carcinoma 2
Advanced Urethral Urothelial Carcinoma 1
Advanced Urothelial Carcinoma 6
Advanced Uterine Carcinosarcoma 1
Advanced Vaginal Adenocarcinoma 2
Advanced Vaginal Adenosquamous Carcinoma 2
Advanced Vaginal Carcinoma 1
Advanced Vaginal Squamous Cell Carcinoma 2
Advanced Vulvar Carcinoma 1
Advanced, Persistent, or Recurrent Endometrial Cancer 1
Advanced-stage Solid Tumors 1
Advanced/ Metastatic Renal Cell Cancer 1